WAVE1 (N-terminal region) Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-WAVE1 (N-terminal region) antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | WAVE1 (N-terminal region) |
| Clone | polyclonal |
| Host Species | Rabbit |
| Reactive Species | human, rat, mouse |
| Isotype | n/a |
| Format | affinity purified |
| Size | 0.1 mL |
| Concentration | n/a |
| Applications | ELISA, Western Blot |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | This antibody was affinity purified using WAVE1 (Nterminal region) peptide (without carrier). The antibody detects an 80 kDa* protein corresponding to the molecular mass of WAVE1 on SDS-PAGE immunoblots of human SYF cSrc-transformed, HUVEC, and K562 cells, as well as rat PC12 cells and mouse C2C12 cells. The Wiskott-Aldrich syndrome protein (WASP) family is involved in various pathways that regulate actin cytoskeletal organization. This family includes WASP, N-WASP, and three WAVE/SCAR isoforms, WAVE1, 2, and 3. WAVE proteins play key roles in actin-mediated cell events, such as membrane ruffling and lamellipodia formation. WAVEs contain an Nterminal WAVE homology domain, a basic domain, a Proline-rich region, and carboxy terminal verprolin |
| Immunogen | Immunogen: A synthetic peptide (coupled to KLH) corresponding to amino acid residues in the N-terminal half of human WAVE1. This sequence has highhomology with similar regions in rat and mouse WAVE1, and has less than 50% homology to similar regions in human WAVE2 and WAVE3. |
| Other Names | [Wiskott-Aldrich syndrome verproline-homologous protein 1; Scar1; WASF1], [WASF1; WASF1; WAVE; SCAR1; WAVE1; FLJ31482; KIAA0269; KIAA0269; SCAR1; WAVE1] |
| Gene, Accession # | Gene ID: 8936, NCBI: NP_001020107.1, UniProt: Q92558 |
| Catalog # | MBS472069 |
| Price | $385 |
| Order / More Info | WAVE1 (N-terminal region) Antibody from MYBIOSOURCE INC. |
| Product Specific References | • Ardern, H. et al. (2006) Cell Motil. Cytosk. 63:6.• Leng, Y. et al. (2005) PNAS 102(4):1098.• Suetsugu, S. et al. (1999) Bioch. Biophs. Res. Comm. 260:296.• Miki, H. et al. (1999) J Biol. Chem. 274(39):27605. |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies